← Search & browse all drugs
VARIOUS › DIAGNOSTIC AGENTS › OTHER DIAGNOSTIC AGENTS › Tuberculosis diagnostics
mycobacterium tuberculosis, recombinant antigens
V04CF02
Forms & Strengths
- Intradermal injection solution containing recombinant M. tuberculosis antigens (e.g., C-Tb)
- Vials containing specific fusion proteins (such as ESAT-6 and CFP-10)
Adult Dosing
- 0.1 mL administered intradermally, typically on the volar surface of the forearm
- Read result for induration at 48 to 72 hours post-injection
Pediatric Dosing
- 0.1 mL administered intradermally (safety and efficacy profiles established similarly to adult populations in specific clinical trials)
- Read result for induration at 48 to 72 hours post-injection
Indications
- Aid in the diagnosis of infection with Mycobacterium tuberculosis (tuberculosis screening/diagnostic test)
- Alternative to the tuberculin skin test (TST) with potentially higher specificity in BCG-vaccinated individuals
Mechanism of Action
- Elicits a delayed-type hypersensitivity (DTH) skin reaction mediated by T-lymphocytes previously sensitized to M. tuberculosis antigens
- Utilizes specific antigens (e.g., ESAT-6, CFP-10) absent in BCG strains and most non-tuberculous mycobacteria, reducing false-positive cross-reactivity
Contraindications
- Known hypersensitivity to recombinant M. tuberculosis antigens or any component of the formulation
- Previous severe local reaction (e.g., necrosis, ulceration) to a previous tuberculin or similar skin test
Adverse Reactions
- Injection site reactions (pain, erythema, pruritus, swelling, induration)
- Local adverse effects such as blistering, ulceration, or necrosis at the injection site in highly sensitized individuals
- Systemic reactions such as mild fever, malaise, or headache (rare)
Drug Interactions
- Immunosuppressive therapies (e.g., systemic corticosteroids, chemotherapy) may cause false-negative test results by impairing the cellular immune response
- Recent live virus vaccinations (e.g., MMR, varicella) may temporarily suppress skin test reactivity
Curated Content: Needs Vetting Before Put to Clinical Use